Overview (20 Jul 2021)
Alkem Laboratories Ltd
ALKEM
INE540L01014

Pharmaceuticals
Result was last declared on 25 May 2021
-53

Prev. Close
Previous Close
3448.7
Current Close
3395.7
Current High
3510.15
Current Low
3381.4
52 Week High
3558.9
52 Week Low
2415.1
Resistance 1
3476.76
Resistance 2
3557.83
Support 1
3348.01
Support 2
3219.26
Std Deviation
3.86%
DMA 200
2893.24
DMA 50
3141.29
DMA 20
3260.21
Fundamentals and Ratios
Standalone
Trailing EPS
140.93
Forwad EPS
140.4
Trailing P/E
24.09
Forward P/E
24.19
PEG Ratio
-64.3226
Mkt. Cap (Cr)
Market Cap (Cr)
40600.69
Total Debt(Cr)
Tot. Debt(Cr)
1670.21
Reserve (Cr)
7352.82
Book Value
616.78
P/BV Ratio
5.51
ROCE(%)
21.00
ROE
26.00
Consolidated
Trailing EPS
132.57
Forwad EPS
129.69
Trailing P/E
25.28
Forward P/E
25.84
PEG Ratio
-11.91
Mkt. Cap (Cr)
Market Cap (Cr)
40068.02
Total Debt(Cr)
Tot. Debt(Cr)
1670.21
Reserve (Cr)
7352.82
Book Value
593.94
P/BV Ratio
5.64
ROCE(%)
21.00
ROE
26.00

 

Financial Result
Standalone
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue1917.471778.751984.11550.851687.527219.68
Other Income48.7772.4624.8432.4525.92190.01
Total Income1966.241851.212008.941583.301713.447409.69
Interest7.368.7714.7612.049.5142.93
Expenditure-1557.80-1394.43-1456.21-1104.17-1407.01-5512.61
PBDT0.000.000.000.000.000.00
Depreciation-49.38-50.08-51.62-47.85-63.76-198.93
PBT395.66456.78552.73479.13306.431884.30
Tax-32.92-55.80-57.53-52.97-35.22-199.22
Equity0.000.000.000.000.000.00
OPM20.6325.6827.8630.8918.1625.00
Net Profit362.74400.98495.2426.16271.211685.08
NPM18.9222.5424.9627.4816.0723
EPS30.3433.5441.4235.6422.68140.93
Consolidated
TypeMar-21Dec-20Sep-20Jun-20Mar-20FY20-21
Revenue2192.162318.052362.82003.492048.998865.01
Other Income46.2896.4035.5443.5027.47233.21
Total Income2238.442414.452398.342046.992076.469098.22
Interest10.7113.0718.0417.1014.1558.92
Expenditure-1980.28-1871.01-1850.59-1554.24-1841.16-7256.12
PBDT0.000.000.000.000.000.00
Depreciation-68.51-69.00-70.24-66.83-81.05-274.58
PBT258.16543.44547.75492.75235.301842.10
Tax-8.94-79.59-66.24-69.56-43.76-224.33
Equity0.000.000.000.000.000.00
OPM11.5322.5122.8424.0711.3320.25
Net Profit249.22463.85481.51423.19191.541617.77
NPM11.1319.2120.0820.679.2217.78
EPS20.0737.7239.4835.315.79132.57
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2021Final Dividend5.00Final Dividend - Rs. - 5.000009 Aug 2021
2021Interim Divvidend25.00Interim Dividend - Rs. - 25.000011 Feb 2021
2020Final Dividend3.00Final Dividend - Rs. - 3.000010 Aug 2020
2020Interim Divvidend22.00Interim Dividend - Rs. - 22.000013 Feb 2020
2019Final Dividend8.00Final Dividend - Rs. - 8.000019 Aug 2019
2019Interim Divvidend8.00Interim Dividend - Rs. - 8.000015 Feb 2019
2018Final Dividend7.00Final Dividend - Rs. - 7.000023 Aug 2018
2018Interim Divvidend6.00Interim Dividend - Rs. - 6.000016 Feb 2018
2017Final Dividend9.00Final Dividend - Rs. - 9.000031 Aug 2017
2017Interim Divvidend6.00Interim Dividend - Rs. - 6.000023 Nov 2016
2016Interim Divvidend9.70Interim Dividend - Rs. - 9.700018 Mar 2016
Bonus
Split
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
730.65
26.42
ABBOTINDIA
17484.45
53.79
AJANTPHARM
2155.25
27.78
ALBERTDAVD
540.8
13.94
ALEMBICLTD
134.5
258.65
ALKEM
3351.15
23.78
AMBALALSA
31.75
-26.02
ANUHPHR
139.2
24.51
APLLTD
968.6
15.97
AREYDRG
37.9
13.58
ARMOURPO
172.05
19.6
ASTRAZEN
3517.35
94.25
AUROLAB
179.1
15.55
AUROPHARMA
975.55
18.36
BAJAJHCARE
918.15
15.24
12345678910
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020